CYTH

Cyclo Therapeutics, Inc. CYTH

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CYTH IVC ELUT RNLX LSB ELEV STRM MSPR TRAW MEIP
6M -3.28 % -30.31 % -58.89 % -69.98 % -51.02 % -39.91 % 74.29 % -93.04 % 69.08 % 63.30 %
YTD 20.10 % 34.65 % -73.64 % -51.27 % -82.63 % -38.67 % 45.72 % -94.37 % -70.36 % 20.39 %
1Y -44.14 % -67.01 % -72.59 % -80.09 % -78.38 % -54.38 % -26.24 % -94.10 % -47.98 % 13.70 %
3Y -75.98 % -91.71 % -88.05 % -99.09 % -99.37 % -70.80 % -77.35 % -94.10 % -85.72 % -59.61 %
5Y -95.76 % -96.18 % -91.85 % -98.47 % -99.34 % -96.81 % -78.05 % -94.10 % -97.26 % -95.06 %
10Y -98.80 % -95.45 % -93.82 % -98.47 % -99.34 % -96.81 % -87.61 % -94.10 % -100.00 % -90.92 %
From the beginning -99.39 % -76.01 % -93.82 % -98.47 % -99.34 % -96.81 % -97.69 % -94.10 % -100.00 % -99.97 %

Dividend

Invacare Corporation

MEI Pharma, Inc.